IBOGAINE Act
In committeeWhat this bill is intended to do
Congress.gov hasn't published an official summary for this bill yet, it usually appears after the bill advances out of committee. The full text is linked below.
Latest action
Jul 17, 2026Referred to the Subcommittee on Health.
D62
Graded by The Quiet Ledger
The IBOGAINE Act aims to accelerate the development and access to psychedelic drugs for treating serious mental illnesses. It establishes a voucher program for priority review of certain drugs, amends the right to try law, and revises DEA quota requirements. The bill also promotes federal-state collaboration and interagency partnerships with the private sector.
Category gradesMembers of The Quiet Ledger see the full per-category breakdown of how this bill was graded.